Edison Oncology Holding Corp. (EOHC)

Edison Oncology Holding will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$8.00 - $10.00

Shares Offered

2,827,777

Deal Size

$25.45M

Edison Oncology Holding Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	0.45	0.38	0.48
Revenue Growth (YoY)	-	-21.73%	-
Gross Profit	0.45	0.38	0.48
Selling, General & Admin	-	1.27	1.46
Research & Development	-	1.1	0.99
Operating Expenses	-	2.37	2.45
Operating Income	-2.66	-1.99	-1.97
Interest Expense / Income	0.4	0.3	0.23
Other Expense / Income	1.28	-1.42	1.96
Pretax Income	-4.34	-0.87	-4.17
Income Tax	0.3	0.3	-0.07
Net Income	-4.64	-1.17	-4.1
Free Cash Flow	-0.94	-1.1	-0.95
Gross Margin	100.00%	100.00%	100.00%
Operating Margin	-596.65%	-528.62%	-409.31%
Profit Margin	-1039.44%	-311.31%	-851.35%
Free Cash Flow Margin	-210.00%	-292.23%	-196.65%
EBITDA	-3.65	-0.35	-3.6
EBITDA Margin	-818.78%	-92.38%	-746.67%
Depreciation & Amortization	0.28	0.22	0.34
EBIT	-3.94	-0.57	-3.93
EBIT Margin	-882.61%	-151.42%	-816.49%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).